FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4361010264> ?p ?o ?g. }

• W4361010264 endingPage "495" @default.
• W4361010264 startingPage "483" @default.
• W4361010264 abstract "The current study aimed to evaluate the synergistic efficacy of lenvatinib and FOLFOX (infusional fluorouracil (FU), folinic acid, and oxaliplatin) in hepatocellular carcinoma (HCC) using patient-derived xenograft (PDX) and PDX-derived organotypic spheroid (XDOTS) models in vivo and in vitro.PDX and matched XDOTS models originating from three patients with HCC were established. All models were divided into four groups and treated with drugs alone or in combination. Tumor growth in the PDX models was measured and recorded, and angiogenesis and phosphorylation of the vascular endothelial growth factor receptor (VEGFR2), rearranged during transfection (RET), and extracellular signal-regulated kinase (ERK) were detected using immunohistochemistry and Western blot assays. The proliferative ability of XDOTS was evaluated through active staining and immunofluorescence staining, and the effect of the combined medication was evaluated using the Celltiter-Glo luminescent cell viability assay.Three PDX models with genetic characteristics similar to those of the original tumors were successfully established. Combining lenvatinib with FOLFOX led to a higher tumor growth inhibition rate than individual therapies (P < 0.01). Immunohistochemical analysis demonstrated that the combined treatment significantly inhibited the proliferation and angiogenesis of PDX tissues (P < 0.05), and Western blot analysis showed that the combined treatment significantly inhibited the phosphorylation of VEGFR2, RET, and ERK compared with single-agent treatment. Additionally, all three matched XDOTS models were successfully cultured with satisfactory activity and proliferation, and the combined therapies led to better suppression of XDOTS growth compared with individual therapy (P < 0.05).Lenvatinib combined with FOLFOX had a synergistic antitumor effect in HCC PDX and XDOTS models by inhibiting the phosphorylation of VEGFR, RET, and ERK." @default.
• W4361010264 created "2023-03-30" @default.
• W4361010264 creator A5001086174 @default.
• W4361010264 creator A5015534012 @default.
• W4361010264 creator A5021714259 @default.
• W4361010264 creator A5029667848 @default.
• W4361010264 creator A5045067652 @default.
• W4361010264 creator A5051510944 @default.
• W4361010264 creator A5058074901 @default.
• W4361010264 creator A5079144442 @default.
• W4361010264 creator A5083635266 @default.
• W4361010264 creator A5085338207 @default.
• W4361010264 date "2023-03-01" @default.
• W4361010264 modified "2023-10-16" @default.
• W4361010264 title "Synergistic Effect of Lenvatinib and Chemotherapy in Hepatocellular Carcinoma Using Preclinical Models" @default.
• W4361010264 cites W1969391810 @default.
• W4361010264 cites W1976262446 @default.
• W4361010264 cites W1978032968 @default.
• W4361010264 cites W2030808027 @default.
• W4361010264 cites W2088484810 @default.
• W4361010264 cites W2094109552 @default.
• W4361010264 cites W2101459399 @default.
• W4361010264 cites W2118952409 @default.
• W4361010264 cites W2121836743 @default.
• W4361010264 cites W2286667211 @default.
• W4361010264 cites W2520739069 @default.
• W4361010264 cites W2574695762 @default.
• W4361010264 cites W2586629973 @default.
• W4361010264 cites W2660993003 @default.
• W4361010264 cites W2782986228 @default.
• W4361010264 cites W2787358630 @default.
• W4361010264 cites W2889646458 @default.
• W4361010264 cites W2898647024 @default.
• W4361010264 cites W2917680953 @default.
• W4361010264 cites W2957800813 @default.
• W4361010264 cites W3001232216 @default.
• W4361010264 cites W3005121071 @default.
• W4361010264 cites W3011919019 @default.
• W4361010264 cites W3036571927 @default.
• W4361010264 cites W3038767246 @default.
• W4361010264 cites W3040646360 @default.
• W4361010264 cites W3081025330 @default.
• W4361010264 cites W3087352129 @default.
• W4361010264 cites W3165133969 @default.
• W4361010264 cites W3194501923 @default.
• W4361010264 cites W3203289704 @default.
• W4361010264 cites W3210942885 @default.
• W4361010264 cites W3211668275 @default.
• W4361010264 cites W3212903603 @default.
• W4361010264 cites W4200494868 @default.
• W4361010264 cites W4206841660 @default.
• W4361010264 cites W4210412789 @default.
• W4361010264 cites W4213281274 @default.
• W4361010264 cites W4229449304 @default.
• W4361010264 cites W4281490101 @default.
• W4361010264 cites W4296848302 @default.
• W4361010264 cites W4311579386 @default.
• W4361010264 cites W4315620068 @default.
• W4361010264 doi "https://doi.org/10.2147/jhc.s395474" @default.
• W4361010264 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37007211" @default.
• W4361010264 hasPublicationYear "2023" @default.
• W4361010264 type Work @default.
• W4361010264 citedByCount "0" @default.
• W4361010264 crossrefType "journal-article" @default.
• W4361010264 hasAuthorship W4361010264A5001086174 @default.
• W4361010264 hasAuthorship W4361010264A5015534012 @default.
• W4361010264 hasAuthorship W4361010264A5021714259 @default.
• W4361010264 hasAuthorship W4361010264A5029667848 @default.
• W4361010264 hasAuthorship W4361010264A5045067652 @default.
• W4361010264 hasAuthorship W4361010264A5051510944 @default.
• W4361010264 hasAuthorship W4361010264A5058074901 @default.
• W4361010264 hasAuthorship W4361010264A5079144442 @default.
• W4361010264 hasAuthorship W4361010264A5083635266 @default.
• W4361010264 hasAuthorship W4361010264A5085338207 @default.
• W4361010264 hasBestOaLocation W43610102641 @default.
• W4361010264 hasConcept C121608353 @default.
• W4361010264 hasConcept C126322002 @default.
• W4361010264 hasConcept C143998085 @default.
• W4361010264 hasConcept C167734588 @default.
• W4361010264 hasConcept C184235292 @default.
• W4361010264 hasConcept C2776264508 @default.
• W4361010264 hasConcept C2777025900 @default.
• W4361010264 hasConcept C2778019345 @default.
• W4361010264 hasConcept C2778260052 @default.
• W4361010264 hasConcept C2778695046 @default.
• W4361010264 hasConcept C2780394083 @default.
• W4361010264 hasConcept C2780962732 @default.
• W4361010264 hasConcept C502942594 @default.
• W4361010264 hasConcept C526805850 @default.
• W4361010264 hasConcept C57074206 @default.
• W4361010264 hasConcept C71924100 @default.
• W4361010264 hasConcept C86803240 @default.
• W4361010264 hasConcept C95444343 @default.
• W4361010264 hasConcept C98274493 @default.
• W4361010264 hasConceptScore W4361010264C121608353 @default.
• W4361010264 hasConceptScore W4361010264C126322002 @default.
• W4361010264 hasConceptScore W4361010264C143998085 @default.
• W4361010264 hasConceptScore W4361010264C167734588 @default.

• next